Takeda Gets Serious About Cell Therapy With TiGenix Buy

 
• By Lucie Ellis-Taitt
  
Crocodile
Takeda snaps up TiGenix for sole rights to IBD cell therapy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business